BMY

Bristol-Myers Squibb Company

41.27 USD
+0.02 (+0.06%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Bristol-Myers Squibb Company stock is down -7.99% since 30 days ago. The next earnings date is Jul 25, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 56.25% of the previous 47 May’s closed higher than April. In the last 10 Unusual Options Trades, there were 6 CALLs, 4 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
24 May 16:43 21 Mar, 2025 40.00 CALL 70 0
24 May 16:45 21 Mar, 2025 40.00 CALL 60 0
24 May 17:04 20 Sep, 2024 39.00 PUT 230 143
24 May 17:27 16 Jan, 2026 25.00 CALL 40 1469
24 May 17:50 17 Jan, 2025 35.00 PUT 1200 7898
24 May 18:08 15 Aug, 2025 40.00 CALL 88 7
24 May 18:22 20 Sep, 2024 42.00 CALL 179 408
24 May 18:39 16 Jan, 2026 40.00 PUT 550 3814
24 May 19:42 21 Jun, 2024 70.00 PUT 10 29
24 May 19:54 21 Mar, 2025 40.00 CALL 60 0

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma.